Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability
Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability have?
Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability has 177 citations in the OpenAlex counts ScholarIQ stores.
When was Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability published?
Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability has 2010 year in the ScholarIQ index.
What is the open-access status of Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability?
Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability has closed oa status in the ScholarIQ index.
What is the DOI of Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability?
The DOI for Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability is on the source record.
What is the PMID of Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability?
The PMID for Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability is on the source record.
What is the OpenAlex record for Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability?
The OpenAlex for Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability is on the source record.